Cover Image

Huisheng Oral Solution Adjunct With Platinum-Based Chemotherapy for the Treatment of Advanced Non-Small Cell Lung Cancer: A Meta-Analysis and Systematic Review

BackgroundPlatinum-based chemotherapy is one of the first line therapies for the advanced non-small cell lung cancer (NSCLC), even though its high toxicity and limited clinical effects cannot be neglected. Huisheng oral solution (HSOS) has been widely used as an adjuvant chemotherapy drug for NSCLC...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jingyi Huang (Author), Zhichao Wang (Author), Han Xue (Author), Ailing Cao (Author), Cassidy Turner (Author), Jing Wang (Author), Li Zhang (Author), Jinghai Wang (Author), Na Xiao (Author), Jie Xu (Author), Xianmei Zhou (Author), Hailang He (Author)
Format:	Book
Published:	Frontiers Media S.A., 2020-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Xiao-ai-ping injection adjunct with platinum-based chemotherapy for advanced non-small-cell lung cancer: a systematic review and meta-analysis
by: Fanchao Feng, et al.
Published: (2020)

LC-MS Based Metabolomics Study of the Effects of EGCG on A549 Cells
by: Tingyu Pan, et al.
Published: (2021)

Efficacy and Safety of Tripterygium Wilfordii Hook. F for Connective Tissue Disease-Associated Interstitial Lung Disease:A Systematic Review and Meta-Analysis
by: Yehui Li, et al.
Published: (2021)

Meta-Analysis of Aidi Injection and First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapy in Treating Advanced Non-Small Cell Lung Cancer
by: Na Xiao MD, et al.
Published: (2021)

Meta-Analysis of Aidi Injection and First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapy in Treating Advanced Non-Small Cell Lung Cancer
by: Na Xiao MD, et al.
Published: (2021)

The Effects of WISP1 Polymorphisms on the Prognosis of Lung Cancer Patients with Platinum-Based Chemotherapy
by: He J, et al.
Published: (2021)

Cost-effectiveness of pembrolizumab plus chemotherapy vs. chemotherapy as first-line treatment for advanced biliary tract cancer in China and the US
by: Xianmei Luo, et al.
Published: (2024)

Nanocarriers containing platinum compounds for combination chemotherapy
by: Guihua Fang, et al.
Published: (2022)

The Association Between Genetic Polymorphisms of Transporter Genes and Prognosis of Platinum-Based Chemotherapy in Lung Cancer Patients
by: He J, et al.
Published: (2022)

Maintenance Therapy with Pembrolizumab after Platinum-Doublet Chemotherapy Leading to Hyperprogression in a Patient with Metastatic Bladder Cancer
by: Yangchun Gu, et al.
Published: (2021)

The Role of ADCY1 in Regulating the Sensitivity of Platinum-Based Chemotherapy in NSCLC
by: Ting Zou, et al.
Published: (2024)

Association of variations in the CAT and prognosis in lung cancer patients with platinum-based chemotherapy
by: Jia-Si Liu, et al.
Published: (2023)

Efficacy and safety of anti-angiogenic drugs combined with chemotherapy in the treatment of platinum-sensitive/resistant ovarian cancer: a meta-analysis with trial sequential analysis of randomized controlled trials
by: Haining He, et al.
Published: (2024)

Systematic Investigation of DNA Methylation Associated With Platinum Chemotherapy Resistance Across 13 Cancer Types
by: Ruizheng Sun, et al.
Published: (2021)

Genome-wide analysis identify novel germline genetic variations in ADCY1 influencing platinum-based chemotherapy response in non-small cell lung cancer
by: Chenxue Mao, et al.
Published: (2022)

Efficacy of a platinum-based chemotherapy rechallenge for platinum-sensitive recurrence after PARP inhibitor maintenance
by: Takehiro Nakao, et al.
Published: (2024)

Genetic Polymorphisms and the Efficacy of Platinum-Based Chemotherapy: Review
by: Afifah NN, et al.
Published: (2020)

Non-Coding RNA Polymorphisms (rs2910164 and rs1333049) Associated With Prognosis of Lung Cancer Under Platinum-Based Chemotherapy
by: Yi-Xin Chen, et al.
Published: (2021)

Predictive Value of Machine Learning for Platinum Chemotherapy Responses in Ovarian Cancer: Systematic Review and Meta-Analysis
by: Qingyi Wang, et al.
Published: (2024)

The value of secondary neoadjuvant chemotherapy in platinum-sensitive recurrent ovarian cancer: a case-control study post GOG-0213 trial
by: Hongyuan Gu, et al.
Published: (2020)

DEVISING AN EXAMINATION SCHEME OF HEARING IN CHILDREN RECEIVED CHEMOTHERAPY WITH PLATINUM
by: G.S Tufatulin, et al.
Published: (2011)

DEVISING AN EXAMINATION SCHEME OF HEARING IN CHILDREN RECEIVED CHEMOTHERAPY WITH PLATINUM
by: G.S Tufatulin, et al.
Published: (2011)

Minimally Modified LDL Upregulates Endothelin Type A Receptors in Rat Coronary Arterial Smooth Muscle Cells
by: Jie Li, et al.
Published: (2013)

Chemotherapy-Induced Peripheral Neurotoxicity and Complementary and Alternative Medicines: Progress and Perspective
by: Xiao-Lan eCheng, et al.
Published: (2015)

Homologous recombination deficiency status predicts response to platinum-based chemotherapy in Chinese patients with high-grade serous ovarian carcinoma
by: Zheng Feng, et al.
Published: (2023)

Ovarian Carcinosarcoma: Effects of Cytoreductive Status and Platinum-Based Chemotherapy on Survival
by: Amelia M. Jernigan, et al.
Published: (2013)

Investigations on incidence and relevant factors of allergies in 5725 urban pregnant women: a cohort study in China
by: Gao Qun, et al.
Published: (2023)

Theurapeutic Response of Neoadjuvant Chemotherapy between Platinum and Ifosfamide Combination and Platinum, Vincristine and Bleomycin Combination in Cervical Carcinoma Stage IB2
by: Kartiwa H Nuryanto, et al.
Published: (2016)

Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Narrative Review
by: Hao Tian, et al.
Published: (2021)

Safety and efficacy of S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy: multi-institutional retrospective analysis
by: Peng PJ, et al.
Published: (2014)

Survival Analysis of Ovarian Carcinosarcomas Depending on Platinum or Doxorubicin Based Adjuvant Chemotherapy
by: İlker Selçuk, et al.
Published: (2016)

Gene polymorphism and prediction of toxicity to platinum‐based chemotherapy in patients with gynecologic cancer
by: Xuan Huang, et al.
Published: (2023)

Assessment of walkability and walkable routes of a 15-min city for heat adaptation: Development of a dynamic attenuation model of heat stress
by: Yu Wang, et al.
Published: (2022)

Theranostic mesoporous platinum nanoplatform delivers halofuginone to remodel extracellular matrix of breast cancer without systematic toxicity
by: Jie Zhang, et al.
Published: (2023)

DNA damage response and repair gene mutations are associated with tumor mutational burden and outcomes to platinum-based chemotherapy/immunotherapy in advanced NSCLC patients
by: Weiguang Gu, et al.
Published: (2023)

Optimisation study on the flavonoid extraction process from Abrus precatorius leaves and the comparison of total flavonoid content by HPLC and UV
by: Xujiang Yuan, et al.
Published: (2023)

The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents
by: Jiabei Zhou, et al.
Published: (2020)

Incidence of persistent and high-risk human papillomavirus infection and associated factors among HIV-positive women in China, 2015-2016
by: Yaping Qiao, et al.
Published: (2021)

The Association Between Heat-Shock Protein Polymorphisms and Prognosis in Lung Cancer Patients Treated With Platinum-Based Chemotherapy
by: Ting Zou, et al.
Published: (2020)

BRCA-mutated gastric adenocarcinomas are associated with chromosomal instability and responsiveness to platinum-based chemotherapy
by: Ji Hyun Oh, et al.
Published: (2023)